SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
| PICOPREP POWDER FOR ORAL SOLUTION | 12,3.5,10 g,g,mg | Powder for oral solution · Oral use | 2 Sachet | SAR 26.75 | NCE · Prescription | FERRING | Valid |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
| CLENPIQ | 12GM/BOT;3.5GM/BOT;10MG/BOT | solution · oral | FERRING PHARMS INC | Prescription | 28 Nov 2017 |
| SODIUM PICOSULFATE, MAGNESIUM OXIDE AND ANHYDROUS CITRIC ACID | 12GM/PACKET;3.5GM/PACKET;10MG/PACKET | for solution · oral | HETERO LABS LTD V | Prescription | 18 Jul 2022 |
| PREPOPIK | 12GM/PACKET;3.5GM/PACKET;10MG/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | for solution · oral | FERRING PHARMS INC | Discontinued | 16 Jul 2012 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
| PICO-SALAX | 02254794 | 12 G / SACHET; 3.5 G / SACHET; 10 MG / SACHET | POWDER FOR SOLUTION · ORAL | FERRING INC |
| PURG-ODAN | 02317966 | 12 G / SACHET; 10 MG / SACHET; 3.5 G / SACHET | POWDER FOR SOLUTION · ORAL | ODAN LABORATORIESLTD |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
| US NADAC | CLENPIQ 175 ML SOLUTION | $0.51785 | per ML | 23 Sep 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.